"The Homoeopathic Drug Proving Trial to find out the effect of placebo and Homoeopathic medicines on healthy individuals using Electro Photonic Imaging Technique"

â??A randomised, blinded, placebo controlled three armed parallel study on Electro Photonic Image changes during Homoeopathic Pathogenetic Trial using molecular and ultra molecular doses - A Reproving" - EPIHPT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012290

Enrollment

150

Registered

2018-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: BELLADONNA-6C: BELLADONNA-6C {dosage pattern- 12 doses

5 globules per dose (03 doses in a day for 04 days)} Intervention2: BELLADONNA-200C: BELLADONNA-200C{dosage pattern- 12 doses

5 globules per dose (03 doses in a day for 04 days)} Control Intervention1: BELLADONNA 6C, BELLADONNA 200C, PLACEBO: FIRST ARM:BELLADONNA 6. SECOND ARM:BELLADONNA 200. THIRD ARM: PLACEBO. DOSAGE: RU

5 globules per dose (03 doses in a day for 04 days)} INTERVENTION PERIOD: FIRST ARM WILL BE TAKING BELLADONNA- 6 , SECOND ARM WILL BE TAKING BELLADONNA- 200, THIRD ARM - PLACEBO. SAME DOSAGE PATTERN A

5 globules per dose (03 doses in a day for 04 days)}

Eligibility

Inclusion criteria

Inclusion criteria: Age of the volunteers should be between 18-40 years. Includes both male and females. Physically and mentally apparently healthy volunteers are taken after general examination procedures and GHQ-12. Volunteers must be 02 months clear of any homoeopathic medicine and no change in health status in last 3 weeks. Volunteers to be intelligent enough to answers the questionnaire and record carefully the facts, subjective and objective symptoms generated during drug proving.

Exclusion criteria

Exclusion criteria: Volunteers suffering from any acute or chronic diseases Volunteers under any kind of medical treatment Hysterical and anxious person Women during pregnancy, puerperium and while breastfeeding Person who undergone surgery in last 02 months Participants in another clinical or proving trial during last 06 months Volunteers having any cut in fingers and/ or absent fingers Volunteers if they had smoked/ taken alcohol on the day of measurement

Design outcomes

Primary

Measure	Time frame
1. EMOTIONAL PRESSURE 2. ENERGY 3. L/R SYMMETRY 4. ORGAN BALANCE 5. ENTROPY COEFFICIENT 6. FORM COEFFICIENT 7. LEFT AREA 8. LEFT ENERGY 9. RIGHT AREA 10. RIGHT ENERGY 11. FRONT AREA 12. FRONT ENERGY Timepoint: AFTER 12 DOSES OF RESPECTIVE INTERVENTIONS	—

Secondary

Measure	Time frame
1. NUMBER OF BELLADONNA SYMPTOMS PRODUCED. Timepoint: AFTER 12 DOSES	—

Countries

India

Contacts

Public ContactDr Banupriya D

Swami Vivekananda Yoga Anusanthana Samsthana (SVYASA)

judu@svyasa.org9035730812

Outcome results